Advertisement Fortitech and BASF terminate joint venture for human nutrition premixes - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Fortitech and BASF terminate joint venture for human nutrition premixes

Fortitech and BASF SE have dissolved their joint venture in the human nutrition premix marketplace and Fortitech will buy all BASF shares. The agreement extends to all joint ventures throughout Europe, South America and Asia.

BASF will continue to supply Fortitech with a broad range of nutritional ingredients, but will discontinue its position within the human nutrition premix business. BASF will continue to provide Fortitech with equal access to top-grade nutritional ingredients as all other customers. Fortitech is using BASF’s top-grade nutritional ingredients in a variety of custom nutrient blends.

Martin Jager, group vice president of nutrition ingredients for BASF, said: “The divestment of BASF in the human nutrition premix joint venture is part of BASF’s strategy to operate efficiently and flexibly in the food and feed markets and, thus, to position BASF Nutrition Ingredients as a sustainable food ingredient supplier to the food industry.”